# Smart SCALEs With Bioimpedance Analysis for Treatment Guidance in Decompensated Heart Failure

Study · id `cardio:ct-nct03288701` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03288701](<https://clinicaltrials.gov/study/NCT03288701>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03288701

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 153 participants.

## Technical summary

Registry record NCT03288701. Allocation not applicable; no masking; primary purpose diagnostic. Start 2017-09-04 (actual); primary completion 2019-09-27 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 153 participants (enrolled count; ClinicalTrials.gov record NCT03288701, source copy `cardio:ctgov-nct03288701-2020-03-25`, retrieved 2026-10-26)
- Started: 2017-09-04 (actual) (ClinicalTrials.gov record NCT03288701, source copy `cardio:ctgov-nct03288701-2020-03-25`, retrieved 2026-10-26)
- Primary completion: 2019-09-27 (actual) (ClinicalTrials.gov record NCT03288701, source copy `cardio:ctgov-nct03288701-2020-03-25`, retrieved 2026-10-26)
- Completion: 2019-09-27 (actual) (ClinicalTrials.gov record NCT03288701, source copy `cardio:ctgov-nct03288701-2020-03-25`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT03288701, source copy `cardio:ctgov-nct03288701-2020-03-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03288701-2020-03-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Smart SCALEs With Bioimpedance Analysis for Treatment Guidance in Decompensated Heart Failure
- Acronym: SCALE HF
- Condition: Heart Failure; With Decompensation
- Intervention (Device): Seca medical Body Composition Analyser 515
- Lead sponsor: University Hospital, Basel, Switzerland
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University Hospital, Basel, Switzerland (`cardio:org-university-hospital-basel-switzerland`)

## Provenance

Content hash: 7e77c00c0f0a1ae2a2e58ae14227a27842f5ea50c7b4a1e3163a4c97baeab808
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
